MD+DI Senior Editor Amanda Pedersen calls on investors, industry leaders, and policymakers to prevent the collapse of the medtech ecosystem as we know it.
In spite of macro uncertainties, healthcare mergers, acquisitions, JVs and other transactions – especially in the MedTech space – are poised to increase, driven by several industry fundamentals: 1.
The third quarter earnings season for MedTech stocks comes at a crucial time, following a tumultuous second quarter that forced investors to recalibrate expectations. As per analysts at Citi Research ...